Teladoc Health Inc $ 193.72 -18.78 (-8.84%)
Volume:
9,609,844
Avg Vol (1m):
3,347,849
Market Cap $:
15.82 Bil
Enterprise Value $:
15.49 Bil
P/E (TTM):
0.00
P/B:
11.83
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.34 | ||
| Equity-to-Asset | 0.54 | ||
| Debt-to-Equity | 0.76 | ||
| Debt-to-EBITDA | -37.32 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 8.95 | ||
| Beneish M-Score | -2.5 | ||
| WACC vs ROIC | |||
Profitability Rank | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -7.53 | ||
| Net Margin % | -13.22 | ||
| ROE % | -8.92 | ||
| ROA % | -5.4 | ||
| ROC (Joel Greenblatt) % | -182.68 | ||
| 3-Year Revenue Growth Rate | 38.3 | ||
| 3-Year EBITDA Growth Rate | 30.7 | ||
| 3-Year EPS without NRI Growth Rate | 7.6 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 11.83 | ||
| PS Ratio | 20 | ||
| Price-to-Free-Cash-Flow | 314.99 | ||
| Price-to-Operating-Cash-Flow | 237.4 | ||
| EV-to-EBIT | -216.68 | ||
| EV-to-EBITDA | -588.66 | ||
| EV-to-Revenue | 21.62 | ||
| Current Ratio | 11.36 | ||
| Quick Ratio | 11.36 | ||
| Days Sales Outstanding | 39.19 | ||
| Days Payable | 15.11 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 45.16 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 20.79 | ||
| Earnings Yield (Greenblatt) % | -0.46 |